Response to Comments: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing

This document is a response-to-comments notice and does not contain specific coverage, exclusion, or documentation requirements for molecular syndromic panels. It refers readers to Local Coverage Determination L39001 (title revised to MolDX: Molecular Syndromic Panels...), notice beginning 2022-03-03 and effective 2022-04-17, for the substantive coverage policy; manual review of L39001 is required to extract coverage criteria.

"This document is a response to public comments and does not itself specify coverage criteria; it references LCD L39001 (MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identificat..."

Sign up to see full coverage criteria, indications, and limitations.